Tze-Chein Wun

Title: The Innovations of Tze-Chein Wun

Introduction

Tze-Chein Wun is a notable inventor based in St. Louis, MO (US), recognized for his significant contributions to the field of biomedical research. He holds a total of 18 patents, showcasing his innovative spirit and dedication to advancing medical science.

Latest Patents

Among his latest patents is the "Anticoagulant combination of LACI and sulfated polysaccharides." This invention discloses a combination of lipoprotein-associated coagulation inhibition (LACI) and sulfated polysaccharides, such as heparin, which exerts a synergistic anticoagulant action in whole plasma. Another significant patent is the "Method of inhibiting intimal hyperplasia," which describes a method for inhibiting intimal hyperplasia in warm-blooded mammals. This method involves administering a small but inhibitorily effective amount of tissue factor pathway inhibitor (TFPI) at the site and time of a vascular injury induced by arterial intervention.

Career Highlights

Throughout his career, Tze-Chein Wun has worked with prominent companies, including Monsanto Company and G.D. Searle & Company. His work in these organizations has contributed to the development of innovative medical solutions and therapies.

Collaborations

Tze-Chein Wun has collaborated with esteemed colleagues, including Kuniko K Kretzmer and George J Broze, Jr. These collaborations have further enriched his research and innovations in the biomedical field.

Conclusion

Tze-Chein Wun's contributions to medical science through his patents and collaborations highlight his role as a leading inventor in the field. His work continues to impact the development of effective medical treatments and therapies.